ORAL-PRO SALICYLIC ACID- salicylic acid concentrate

ORAL-PRO SALICYLIC ACID by

Drug Labeling and Warnings

ORAL-PRO SALICYLIC ACID by is a Animal medication manufactured, distributed, or labeled by Aurora Pharmaceutical, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

INDICATIONS:

A liquid salicylic acid concentrated solution for use in animals.

INGREDIENTS:

Salicylic Acid . . . . . . . . . . . . 9.2% w/w

DIRECTIONS FOR USE:

Use between 1 and 32 ounces in 128 gallons of water, or 1 to 4 ounces per gallon of stock solution at 1:128.

WARNING:

Do not administer concentrated solution by direct oral administration — gastrointestinal irritation or overdose may occur.

STORAGE AND HANDLING

Store at 20°–25° C (68°–77° F). Excursions permitted between 15°–30° C (59°–86° F). Do not freeze.

CAUTION:

Keep container closed when not in use. Salicylic Acid crystals may form at cold storage temperatures. Place bottle in warm water and gently invert to dissolve crystals.

FLAMMABLE - USE WITH CAUTION

Consumer Commodity ORM-D

SPL UNCLASSIFIED SECTION

REORDER NO: 21006

MANUFACTURED BY:
Aurora Pharmaceutical, LLC
NORTHFIELD, MINNESOTA 55057
888-215-1256
www.aurorapharmaceutical.com
IN 50-1312 05/2013

MANUFACTURED IN THE USA

PRINCIPAL DISPLAY PANEL - 946 mL Bottle Label

NDC: 51072-040-02

ORAL-PRO™

Salicylic Acid Concentrate

Contains Salicylic Acid (9.2%)

For Animal Use Only

KEEP OUT OF REACH OF CHILDREN

32 fl. oz. (946 ml)

AURORA PHARMACEUTICAL®

INGREDIENTS AND APPEARANCE

ORAL-PRO SALICYLIC ACID 
salicylic acid concentrate

Product Information
Product Type	OTC ANIMAL DRUG	Item Code (Source)	NDC: 51072-040
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	7.9 g  in 100 mL

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 51072-040-02	946 mL in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		06/28/2013	09/30/2022

Labeler - Aurora Pharmaceutical, Inc. (832848639)

Establishment
Name	Address	ID/FEI	Business Operations
Aurora Pharmaceutical, Inc.		832848639	MANUFACTURE